Fig. 3: New model combining CPPs with RBMS1 predicts poor clinical outcomes in GC better than CPPs alone. | Cell Death & Disease

Fig. 3: New model combining CPPs with RBMS1 predicts poor clinical outcomes in GC better than CPPs alone.

From: RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling

Fig. 3

A–C Calibration plots of the nomogram-predicted and observed 1-, 3- and 5-year survival rates. The nomogram-predicted probability of survival was plotted on the x-axis, and actual survival was plotted on the y-axis. Dashes: ideal model; vertical bars, 95% confidence interval. D Time-dependent receiver operating characteristic (ROC) analysis showed that the combination of RBMS1 with CPPs increased the prediction accuracy of traditional CPPs for overall survival. E Nomogram for predicting 1-, 3-, and 5-year survival in GC patients. CPPs, clinicopathological parameters.

Back to article page